Apollomics, Inc. (APLM)
NASDAQ: APLM · Real-Time Price · USD
19.99
+1.34 (7.18%)
At close: Feb 11, 2026, 4:00 PM EST
19.60
-0.39 (-1.95%)
After-hours: Feb 11, 2026, 7:07 PM EST
Apollomics Market Cap
Apollomics has a market cap or net worth of $42.9 million as of February 11, 2026. Its market cap has increased by 309.98% in one year.
Market Cap
42.90M
Enterprise Value
41.55M
1-Year Change
309.98%
Ranking
Category
Stock Price
$19.99
Market Cap Chart
Since November 26, 2021, Apollomics's market cap has decreased from $129.59M to $42.90M, a decrease of -66.89%. That is a compound annual growth rate of -23.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 40.03M | -0.24% |
| Dec 31, 2025 | 40.12M | 273.20% |
| Dec 31, 2024 | 10.75M | -87.56% |
| Dec 29, 2023 | 86.40M | -37.89% |
| Dec 30, 2022 | 139.11M | 7.02% |
| Dec 30, 2021 | 129.98M | 0.30% |
| Nov 26, 2021 | 129.59M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CEL-SCI | 42.46M |
| LeonaBio | 41.54M |
| Atossa Therapeutics | 41.51M |
| Lisata Therapeutics | 40.58M |
| Telomir Pharmaceuticals | 40.46M |
| NextCure | 40.45M |
| INmune Bio | 40.14M |
| PDS Biotechnology | 39.54M |